LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 91 filers reported holding LEGEND BIOTECH CORP in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,145 | -11.0% | 71 | +12.7% | 0.00% | – |
Q1 2024 | $3,534 | -17.3% | 63 | -11.3% | 0.00% | – |
Q4 2023 | $4,273 | +176.6% | 71 | +208.7% | 0.00% | – |
Q3 2023 | $1,545 | -2.7% | 23 | 0.0% | 0.00% | – |
Q2 2023 | $1,588 | +43.1% | 23 | 0.0% | 0.00% | – |
Q1 2023 | $1,110 | +71.0% | 23 | +76.9% | 0.00% | – |
Q4 2022 | $649 | – | 13 | +62.5% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 8 | -96.3% | 0.00% | -100.0% |
Q4 2021 | $10,000 | -28.6% | 214 | -23.6% | 0.00% | -50.0% |
Q3 2021 | $14,000 | +27.3% | 280 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $11,000 | +37.5% | 280 | 0.0% | 0.00% | +100.0% |
Q1 2021 | $8,000 | +33.3% | 280 | +40.0% | 0.00% | 0.0% |
Q4 2020 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |